Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts

PURPOSE: (1) To determine TweakR expression in human breast cancers (BC), (2) evaluate the antitumor effect of the anti-TweakR antibody PDL192, used alone or after chemotherapy-induced complete remission (CR), on patient-derived BC xenografts (PDX) and (3) define predictive markers of response. EXPE...

Descripción completa

Detalles Bibliográficos
Autores principales: de Plater, Ludmilla, Vincent-Salomon, Anne, Berger, Frédérique, Nicolas, André, Vacher, Sophie, Gravier, Eléonore, Thuleau, Aurélie, Karboul, Narjesse, Richardson, Marion, Elbaz, Clément, Marangoni, Elisabetta, Bièche, Ivan, Paoletti, Xavier, Roman-Roman, Sergio, Culp, Patricia A., Asselain, Bernard, Diéras, Véronique, Decaudin, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222831/
https://www.ncbi.nlm.nih.gov/pubmed/25375638
http://dx.doi.org/10.1371/journal.pone.0104227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222831/
https://www.ncbi.nlm.nih.gov/pubmed/25375638
http://dx.doi.org/10.1371/journal.pone.0104227

Ejemplares similares